JP2009542609A5 - - Google Patents

Download PDF

Info

Publication number
JP2009542609A5
JP2009542609A5 JP2009517409A JP2009517409A JP2009542609A5 JP 2009542609 A5 JP2009542609 A5 JP 2009542609A5 JP 2009517409 A JP2009517409 A JP 2009517409A JP 2009517409 A JP2009517409 A JP 2009517409A JP 2009542609 A5 JP2009542609 A5 JP 2009542609A5
Authority
JP
Japan
Prior art keywords
wnt5a
derivative
therapeutically effective
fragment
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009517409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009542609A (ja
Filing date
Publication date
Priority claimed from GBGB0613031.4A external-priority patent/GB0613031D0/en
Application filed filed Critical
Publication of JP2009542609A publication Critical patent/JP2009542609A/ja
Publication of JP2009542609A5 publication Critical patent/JP2009542609A5/ja
Pending legal-status Critical Current

Links

JP2009517409A 2006-06-30 2007-06-29 薬剤 Pending JP2009542609A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0613031.4A GB0613031D0 (en) 2006-06-30 2006-06-30 Medicaments
PCT/GB2007/002445 WO2008001113A2 (en) 2006-06-30 2007-06-29 Use of wnt5a for inhibiting scarring

Publications (2)

Publication Number Publication Date
JP2009542609A JP2009542609A (ja) 2009-12-03
JP2009542609A5 true JP2009542609A5 (https=) 2010-08-19

Family

ID=36888398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009517409A Pending JP2009542609A (ja) 2006-06-30 2007-06-29 薬剤

Country Status (11)

Country Link
US (1) US20100137201A1 (https=)
EP (1) EP2046364A2 (https=)
JP (1) JP2009542609A (https=)
CN (1) CN101511383A (https=)
AU (1) AU2007263593A1 (https=)
BR (1) BRPI0713807A2 (https=)
CA (1) CA2656965A1 (https=)
GB (1) GB0613031D0 (https=)
MX (1) MX2008016520A (https=)
WO (1) WO2008001113A2 (https=)
ZA (1) ZA200900708B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702930D0 (en) * 2007-02-15 2007-03-28 Renovo Ltd Medicaments and methods for inhibition of scarring
WO2009047330A1 (en) * 2007-10-12 2009-04-16 Universite Louis Pasteur Use of wnt5a for treating or preventing obesity and atherosclerosis
CN101790221B (zh) * 2009-01-22 2015-05-06 中兴通讯股份有限公司 家用基站切换时网络接入控制方法及系统
EP2226080A1 (en) * 2009-03-05 2010-09-08 Universiteit Maastricht Antagonistic peptides for frizzled-1 and frizzled-2
CN117379543A (zh) * 2017-08-20 2024-01-12 加州大学董事会 治疗青光眼的Wnt5a的调节

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485972B1 (en) * 1998-10-15 2002-11-26 President And Fellows Of Harvard College WNT signalling in reproductive organs
US20040087016A1 (en) * 2000-05-12 2004-05-06 University Of Utah Research Foundation Compositions and methods for cell dedifferentiation and tissue regeneration
CA2408701A1 (en) * 2000-05-12 2001-11-22 University Of Utah Research Foundation Compositions and methods for tissue dedifferentiation and regeneration
EP1383789A2 (en) * 2001-04-06 2004-01-28 Incyte Genomics, Inc. Proteins associated with cell growth, differentiation, and death
WO2004047757A2 (en) * 2002-11-21 2004-06-10 University Of Massachusets Diagnosing and treating hematopoietic cancers
EP1622637A2 (en) * 2003-05-15 2006-02-08 The University of Chicago Method and compositions for nerve regeneration
WO2005118782A2 (en) * 2004-04-16 2005-12-15 Hydra Biosciences, Inc. Methods of promoting cardiac cell proliferation
ATE550423T1 (de) * 2004-08-30 2012-04-15 Theregen Inc Dreidimensionale kultivierte gewebe und deren verwendung

Similar Documents

Publication Publication Date Title
JP2006515351A5 (https=)
JP2020073529A5 (https=)
JP2009510044A5 (https=)
JP2017528507A5 (https=)
JP2020524689A5 (https=)
JP2016516016A5 (https=)
JP2019524897A5 (https=)
JP2015517489A5 (https=)
JP2007500236A5 (https=)
JP2014526441A5 (https=)
NZ600544A (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
RU2013139651A (ru) Новые соединения, влияющие на пищевое поведение
JP2007533687A5 (https=)
CA2730789A1 (en) Treatment of inflammatory bowel diseases with mammal beta defensins
JP2018516992A5 (https=)
JP2005501110A5 (https=)
JP2010532761A5 (https=)
JP2009542609A5 (https=)
JP2014510082A (ja) インターロイキン−1受容体のアンタゴニスト
JP2009544585A5 (https=)
JP2020514305A5 (https=)
JP2010519192A5 (https=)
JP2007077148A (ja) うつ病患者における睡眠障害の処置を目的とした医薬品を得るためのアゴメラチンの使用
JP6960415B2 (ja) 三叉神経痛を予防又は治療する目的のためのカルバメート化合物の使用
JP2010524910A5 (https=)